IGM Biosciences Inc reports results for the quarter ended in March - Earnings Summary

IGM Biosciences

12/05/2023 19:42

* IGM Biosciences Inc  IGMS.OQ  reported a quarterly
adjusted loss
of $1.33​​ per share for the quarter ended in March. The mean
expectation of nine analysts for the quarter was for a loss of
$1.36 per share.
    * Revenue was $522.00 thousand​; analysts expected $1.64
million. 
    * IGM Biosciences Inc's reported EPS for the quarter was a
loss of
$1.33​.
    * The mean earnings estimate of analysts had risen by
about 8.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * IGM Biosciences Inc shares had fallen by 6.0% this
quarter and
lost 24.0% so far this year.
    * The company reported a quarterly loss of $59.31 million.
    * Wall Street's median 12-month price target for IGM
Biosciences
Inc is $33.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
12 at 06:42 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -1.36          -1.33          Beat
 Dec. 31 2022      -1.25          -1.19          Beat
 Sep. 30 2022      -1.43          -1.32          Beat
 Jun. 30 2022      -0.94          -1.33          Missed